相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis
Ai-Lan Cheng et al.
CLINICAL CANCER RESEARCH (2008)
14-3-3σ Modulates Pancreatic Cancer Cell Survival and Invasiveness
Divas Neupane et al.
CLINICAL CANCER RESEARCH (2008)
Radiotherapy Combined with Gemcitabine and Oxaliplatin in Pancreatic Cancer Cells
Meredith A. Morgan et al.
TRANSLATIONAL ONCOLOGY (2008)
Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development
Zhaoqian Liu et al.
DIFFERENTIATION (2007)
Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity
Junkang Xu et al.
CANCER RESEARCH (2007)
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor
Takashi Suzuki et al.
CANCER SCIENCE (2007)
Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3σ
BG Han et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Identification of 14-3-3σ as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis
Y Liu et al.
CANCER RESEARCH (2006)
14-3-3σ Methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival:: The Spanish Lung Cancer Group
JL Ramirez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mcl-1 vascular endothelial growth factor-R2, and 14-3-3σ expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck
BM Erovic et al.
CLINICAL CANCER RESEARCH (2005)
14-3-3σ in endometrial cancer -: A possible prognostic marker in early-stage cancer
K Ito et al.
CLINICAL CANCER RESEARCH (2005)
Targeted proteomic analysis of 14-3-3σ, a p53 effector commonly silenced in cancer
A Benzinger et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
14-3-3σ expression 9s an independent prognostic parameter for poor survival in colorectal carcinoma patients
A Perathoner et al.
CLINICAL CANCER RESEARCH (2005)
Expression and prognostic significance of 14-3-3σ and ERM family protein expression in periampullary neoplasms
SR Hustinx et al.
CANCER BIOLOGY & THERAPY (2005)
Loss of 14-3-3σ in prostate cancer and its precursors
L Cheng et al.
CLINICAL CANCER RESEARCH (2004)
Distribution and significance of 14-3-3σ, a novel myoepithelial marker, in normal, benign, and malignant breast tissue
PT Simpson et al.
JOURNAL OF PATHOLOGY (2004)
Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis
A Guweidhi et al.
CARCINOGENESIS (2004)
Tumor suppressor gene 14-3-3σ is down-regulated whereas the proto-oncogene translation elongation factor 1δ is up-regulated in non-small cell lung cancers as identified by proteomic profiling
Y Liu et al.
JOURNAL OF PROTEOME RESEARCH (2004)
14-3-3 proteins in the nervous system
D Berg et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer
H Friess et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays
CA Iacobuzio-Donahue et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Decreased expression of 14-3-3σ in neuroendocrine tumors is independent of origin and malignant potential
Y Yatabe et al.
ONCOGENE (2002)
Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth
T Urano et al.
NATURE (2002)
Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers
H Osada et al.
ONCOGENE (2002)
Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia
M Gasco et al.
ONCOGENE (2002)
The G2/M regulator 14-3-3σ prevents apoptosis through sequestration of Bax
T Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
14-3-3 proteins: key regulators of cell division, signalling and apoptosis
MJ van Hemert et al.
BIOESSAYS (2001)
Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
CB Umbricht et al.
ONCOGENE (2001)
14-3-3 proteins: regulation of subcellular localization by molecular interference
AJ Muslin et al.
CELLULAR SIGNALLING (2000)
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma
N Iwata et al.
ONCOGENE (2000)
Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression
C Laronga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
AT Ferguson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis
DB Villaret et al.
LARYNGOSCOPE (2000)
分享论文
